Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05025787 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.
A Phase 2 study of Knee Osteoarthritis, sponsored by Maurizio Fava, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
- 16
- Study locations
NCT05025787 is a Phase 2 study of Knee Osteoarthritis that has completed, run by Maurizio Fava, MD. The registered enrollment target is 55 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (82% lower). The trial reports 16 study locations across 10 states.
The verdict
NCT05025787, a Phase 2 study of Knee Osteoarthritis, has completed, sponsored by Maurizio Fava, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
- 16
- Study locations
Study Summary
The primary objective of this study is to evaluate the safety and efficacy of CNTX-6970 for the treatment of pain related to OA of the knee compared to placebo. CNTX-6970 is being developed as a new treatment for chronic pain, including painful osteoarthritis of the knee.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG CNTX-6970
Study Locations (16)
New York
- New York University Langone Health - New York
- Icahn School of Medicine at Mount Sinai - New York
- University of Rochester - Rochester
- Montefiore Medical Center - The Bronx
California
- University of California San Diego - La Jolla
- University of California- Davis - Sacramento
Florida
- University of Florida - Gainesville
- M&M Clinical Trials - Miami
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Massachusetts
- Massachusetts General Hospital - Boston
Missouri
- Healthcare Research Network - Hazelwood
North Carolina
- Center for Clinical Research - Winston-Salem
Texas
- UTsouthwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2024-06-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05025787
The ClinicalTrials.gov registry entry for NCT05025787 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (82% lower). The listed sponsor is Maurizio Fava, MD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05025787 reports 16 study locations spanning 10 distinct geographic areas - top geographies include New York, California, Florida.
Frequently Asked Questions
What is clinical trial NCT05025787 about?
NCT05025787 is a clinical study titled "A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.". The primary objective of this study is to evaluate the safety and efficacy of CNTX-6970 for the treatment of pain related to OA of the knee compared to placebo. CNTX-6970 is being developed as a new treatment for chronic pain, including painful osteoarthritis of the knee.
What is the current status of trial NCT05025787?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2021-10-25. Estimated completion is 2024-06-11.
What conditions does trial NCT05025787 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT05025787?
The interventions under investigation include: Placebo (DRUG), CNTX-6970 (DRUG).
Who is sponsoring clinical trial NCT05025787?
This trial is sponsored by Maurizio Fava, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05025787 being conducted?
This trial has 16 study locations across California, Florida, Massachusetts, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis
RECRUITING · Phase 2
-
Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA
RECRUITING · Phase 2
-
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
RECRUITING · Phase 2
-
Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis
RECRUITING · Phase 2
-
A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees
COMPLETED · Phase 2
-
Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.